Submission Details

Submitter:

Classification:
Definitive
GENCC:100001
Gene:
Disease:
neurodevelopmental disorder with or without variable brain abnormalities; NEDBA
Mode Of Inheritance:
Autosomal dominant
Evaluated Date:
05/22/2022
Evidence/Notes:

The MAPK8IP3 gene is located on chromosome 16 at 16q13.3 and encodes the Mitogen-Activated Protein Kinase 8 Interacting Protein 3, one of the family of JNK-interacting protein group of scaffold proteins. MAPK8IP3 was first reported in relation to autosomal dominant MAPK8IP3-related neurodevelopmental disorders in 2019 (Platzer et al., PMID: 30612693). 7 variants (including 4 missense, 2 nonsense, and 1 frameshift) have been reported in 9 probands in 2 publications (PMID: 30612693; Iwasawa et al., 2019, PMID: 30945334) and are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of the disease is not yet established. However, it is known that the protein encoded by MAPK8IP3 acts as a regulator of vesicle transport and promotes neuronal axon elongation in a kinesin- and JNK-dependent manner. Both missense variants located in functional domains and null variants, all of which are de novo, are implicated in disease. This gene-disease relationship is also supported by experimental evidence (e.g. animal models, rescue and expression studies) (Gowrishankar et al., 2017, PMID: 28784610; PMID: 30612693). In summary, MAPK8IP3 is definitively associated with autosomal dominant MAPK8IP3-related neurodevelopmental disorder with or without variable brain abnormalities. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Syndromic Disorders Gene Curation Expert Panel on the meeting date 10.26.2021 (SOP Version 8).

PubMed IDs:
28784610 29022597 30612693 30945334
Public Report:
Assertion Criteria:
Submitter Submitted Date:
12/05/2025

The GenCC data are available free of restriction under a CC0 1.0 Universal (CC0 1.0) Public Domain Dedication. The GenCC requests that you give attribution to GenCC and the contributing sources whenever possible and appropriate. The accepted Flagship manuscript is now available from Genetics in Medicine (https://www.gimjournal.org/article/S1098-3600(22)00746-8/fulltext).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. The GenCC does not independently verify the submitted information. Though the information is obtained from sources believed to be reliable, no warranty, expressed or implied, is made regarding accuracy, adequacy, completeness, reliability or usefulness of any information. This disclaimer applies to both isolated and aggregate uses of the information. The information is provided on an "as is" basis, collected through periodic submission and therefore may not represent the most up-to-date information from the submitters. If you have questions about the medical relevance of information contained on this website, please see a healthcare professional; if you have questions about specific gene-disease claims, please contact the relevant sources; and if you have questions about the representation of the data on this website, please contact gencc@thegencc.org.